Mortality, Intensive Care Unit Admission, and Intubation among Hospitalized Patients with COVID-19: A One-Year

Khaled Al Oweidat1,2, Rasmieh Al-Amer3,4, Mohammad Y Saleh5

  • 1Department of Respiratory and Sleep Medicine, Faculty of Medicine, The University of Jordan, Amman 11942, Jordan.

Insights

This study identified key factors predicting COVID-19 severity in Jordanian patients. Chronic kidney disease and low oxygen saturation were linked to higher mortality, informing risk stratification for severe COVID-19 outcomes.

Area of Science:

  • * Infectious Diseases
  • * Public Health
  • * Critical Care Medicine

Background:

  • * The COVID-19 pandemic presented significant challenges to healthcare systems globally.
  • * Understanding risk factors for severe COVID-19 outcomes is crucial for patient management and resource allocation.

Purpose of the Study:

  • * To identify factors associated with COVID-19 mortality.
  • * To determine predictors of intensive care unit (ICU) admission and invasive intubation.
  • * To analyze factors influencing length of hospital stay in Jordanian COVID-19 patients.

Main Methods:

  • * A retrospective study involving 745 COVID-19 patients admitted to Jordan University Hospital over one year.
  • * Data collection included demographics, comorbidities, clinical parameters, laboratory results, and outcomes (mortality, ICU admission, intubation).
  • * Statistical analysis was performed to identify significant associations between variables and outcomes.

Main Results:

  • * Overall mortality, ICU admission, and invasive intubation rates were 23.0%, 28.3%, and 10.8%, respectively.
  • * Mortality was associated with chronic kidney disease (CKD), elevated troponin, lactate dehydrogenase (LDH), and oxygen saturation <90%.
  • * ICU admission linked to heart failure and remdesivir use; invasive intubation associated with oxygen saturation <90% and gastrointestinal symptoms.

Conclusions:

  • * Specific clinical and laboratory parameters can predict COVID-19 severity and adverse outcomes.
  • * Identifying high-risk populations is essential for targeted interventions and improved patient care.
  • * Findings can inform future research on COVID-19 complications and risk stratification.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
305
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
296
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
258
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
239
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
174
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15